Johnson & Johnson vaccine recommended for Canadians 30 and older despite risk of rare blood clots
Canada now recommends the Johnson & Johnson vaccine for all Canadians 30 years of age and older, but officials also say to weigh the risk of rare but potentially serious blood clots that can occur from the vaccine against COVID-19 levels in the community — or hold out for another shot altogether.